BioSpace News Archive

Integral Molecular has launched an expanded panel of SARS-CoV-2 Reporter Virus Particles (RVP), which includes spike protein variants such as D614G and spike protein from other related coronaviruses.

Sixteen finalists are announced in the “Make Your Medical Device Pitch for Kids!” special COVID-19 edition competition presented by the National Capital Consortium for Pediatric Device Innovation (NCC-PDI).

UVC Protected (https://uvcprotected.com/) recently announced a powerful new weapon in the fight against pathogenic disease spread: the patent-pending Clean Touch device.

DSE Healthcare Solutions recharges its legacy brand VANQUISH® to meet the needs of today’s consumer with the launch of VANQUISH® DIGITAL HEADACHE™ Brand Pain Reliever.

This new partnership will offer comprehensive pediatric surgical services for patients in the Tampa Bay community.

ReviveMed is proud to announce that they are pursuing an evaluation study with Bristol Myers Squibb (NYSE: BMY). This study will leverage ReviveMed’s artificial intelligence (AI) platform to better understand mechanisms of response and resistance to immunotherapies in patients with cancer. “We are very excited about this opportunity to work alongside industry leaders on the Bristol Myers Squibb team,” said Dr. Leila

Kemin Industries, a global ingredient manufacturer that strives to sustainably transform the quality of life every day for 80 percent of the world with its products and services, has acquired a U.S. patent application for a method to control African Swine Fever virus (ASFv) in feed and feed ingredients using Sal CURB® Liquid Antimicrobial – a global pathogen control product manufactured by Kemin.

AccuVein Inc., the global leader in vein visualization technology announced today two strategic hires: Kevin McArdle as Chief Financial Officer and Philip Spiegel as Chief Sales Officer

PhotoPharmics, a pioneer in specialized phototherapy for neurodegenerative diseases, today announced a collaboration with the Center for Health + Technology (CHeT) at the University of Rochester Medical Center to conduct an at home, telemedicine, phase 3 trial to establish safety and efficacy for the company’s non-invasive specialized phototherapy device for Parkinson’s disease.

AccuReg, a healthcare technology solutions company, offers hospitals across the country a suite of price transparency solutions that will ensure they meet and exceed the new government compliance requirements that must be implemented by January 2021.